Unbiased AI-powered news
A spokesman for the Kennedy organization resigned in a letter to President Trump. The official opposed a decision to permit the sale of flavored e-cigarettes, stating it would increase their appeal to children. The New York Times reported the resignation on May 13, 2026.
nbcnews.comA top spokesman for the Kennedy organization has resigned in protest over a new policy that allows the sale of flavored e-cigarettes. In a letter to President Trump, the spokesman, Rich Danker, said the moves would enhance the products' appeal to children.
The policy change reverses previous restrictions on flavored vaping products. Officials had previously cited concerns about youth access and use. The decision to permit sales of the flavored versions prompted the internal objection.
Danker submitted his resignation directly to the president. His letter outlined the specific objection to the flavored e-cigarette provision. No further details about the timing of the policy decision were provided in the report.
The development comes amid ongoing debates over how to regulate vaping products. Federal authorities continue to review data on youth vaping rates and potential health effects. The spokesman’s departure highlights divisions within health policy circles over the balance between adult access and youth protection.
These outlets didn't split into competing frames — coverage was uniform.
Los Angeles TimesThe Defense Department reinstated required flu vaccinations for new recruits after an outbreak at Lackland Air Force Base sickened nearly 300 people. The reversal ends a policy that had made the shots optional for the first time in 70 years.
Nbc NewsSens. Kirsten Gillibrand and Eric Schmitt urged Defense Secretary Peter Hegseth to remove rules limiting Applied Behavior Analysis therapy under TRICARE. The letter followed an NBC News report detailing coverage denials for military families. It seeks to designate the therapy as…
upi.comThe legislation would let drugmakers issue retroactive rebates and impose new rules on hospitals and contract pharmacies. Separately, the Trump administration is considering Jeff Vacirca to lead the FDA.